Rockefeller Capital Management L.P. Heron Therapeutics, Inc. Transaction History

Rockefeller Capital Management L.P.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 02, 2022	SELL	$2.66 - $5.37 $2,769 - $5,590	-1,041 Reduced 83.88%	200 $0
Q2 2022 Aug 12, 2022	BUY	$2.3 - $6.29 $2,394 - $6,547	1,041 Added 520.5%	1,241 $3,000
Q4 2021 Feb 14, 2022	SELL	$8.35 - $12.6 $7,515 - $11,340	-900 Reduced 81.82%	200 $1,000
Q3 2021 Nov 12, 2021	SELL	$10.13 - $15.0 $1,114 - $1,650	-110 Reduced 9.09%	1,100 $11,000
Q1 2021 May 11, 2021	BUY	$14.49 - $20.72 $14,634 - $20,927	1,010 Added 505.0%	1,210 $19,000
Q1 2020 May 12, 2020	BUY	$10.23 - $24.56 $2,046 - $4,912	200 New	200 $2,000

193

129M

94.7K

148K

Ticker HRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,774,000
Market Cap $227M
Description
Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...

Get notified when there are updates to the investment portfolio of Rockefeller Capital Management L.P., based on Form 13F filings with the SEC.

Stay updated on Rockefeller Capital Management L.P. with notifications on news.